Roche secures Zealand obesity drug candidate for up to $5.3 billion
Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as the Swiss drugmaker
Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as the Swiss drugmaker
Germany's financial markets watchdog has started an initial probe to examine whether Bayer fairly disclosed plans to get shareholder approval for a potential
Bayer told several brokerages about plans to seek shareholder permission to issue shares one day before formally announcing the news on Friday, which weighed
Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against product liability
Bayer on Wednesday raised the prospect of a return to earnings growth from 2026 after a decline this year, lifting its shares to a four-month high as its CEO
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, clinical trial experts and doctors
Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by Blackstone's drug development unit, for
Roche said on Thursday it is targeting a continued increase in adjusted earnings per share (EPS) at a high single-digit percentage this year, helped by lower
SAP, Europe's largest software maker, said on Tuesday it was more optimistic about its financial results this year due to faster growth in
Germany's government and opposition parties duelled on Monday over rival border control policies, with opposition leader Friedrich Merz, favourite
The leader of Germany's conservative CDU, the party's candidate to run for chancellor, said on Tuesday that the nation should focus on efforts to reach existing
Scientists Moungi Bawendi, Louis Brus and Aleksey Ekimov won the 2023 Nobel Prize in Chemistry for their discovery of tiny clusters of atoms
Shares of Pfizer and German partner BioNTech fell on Monday after the U.S. drugmaker slashed the sales forecast for its COVID vaccine and therapy last week, and some
Eli Lilly will build its first plant in Germany for 2.3 billion euros ($2.5 billion) in the western town of Alzey, the U.S. pharmaceuticals maker said on
Germany's Bayer has aborted a large late-stage trial testing a new anti-clotting drug due to lack of efficacy, dealing a fresh blow to the embattled drugmaker and throwing
Roche agreed to take over obesity drug developer Carmot Therapeutics for $2.7 billion, joining a list global contestants seeking to challenge the dominant makers of weight
Bayer beat first-quarter analyst forecasts as it reported a slight drop in adjusted earnings on Tuesday, providing a respite for the CEO's turnaround efforts.
Thyssenkrupp on Thursday said its supervisory board approved a planned sale of 20% of the conglomerate's steel division to Czech billionaire
Eli Lilly on Thursday said it has not yet gained approval in Britain for the injection pen it plans to use for its Mounjaro drug against obesity and
Roche will end a lung cancer trial testing its new immunotherapy after the drug did not show a benefit over established treatment Keytruda by Merck
Austrian prosecutors said they will bring criminal charges against two men accused of selling fake versions of Novo Nordisk's diabetes drug
Germany's armed forces are in talks to order about 100 Boxer armoured vehicles from German-French defence contractor KNDS for use by Ukraine, news
Deutsche Lufthansa slashed its 2024 earnings guidance for a second time and issued a profit warning for its second
Bayer said on Wednesday its Nubeqa drug was shown to slow the progression of a certain type of prostate cancer in a late-stage trial, underpinning growth
Roche said on Wednesday a second drug candidate from its purchase of Carmot Therapeutics yielded positive results in an early-stage trial, as the Swiss
Your subscription includes
Unlimited Access to All Content from
The Los Angeles Post
Your subscription has been successfully upgraded!